Nav: Home

New national Lyme Disease Biobank to accelerate research by making samples available

January 24, 2017

Portola Valley, Calif., Jan. 24, 2017 - Bay Area Lyme Foundation, a national organization funding research to make Lyme disease easy to diagnose and simple to cure, announces the launch of the Lyme Disease Biobank, which is the first program to provide researchers with blood and urine samples from people with acute Lyme disease from multiple regions across the country, including the East Coast, West Coast and Upper Midwest.

"One of the biggest barriers to research is a lack of samples from people confirmed to have Lyme disease - our program aims to alleviate this," said Liz Horn, PhD, MBI, principal investigator, Lyme Disease Biobank. "Our efforts will unlock a huge bottleneck and make it possible for more scientists to conduct desperately needed research in Lyme disease."

The Lyme Disease Biobank will dramatically increase the volume of well-characterized samples to enable research efforts to accelerate medical breakthroughs in the understanding, diagnosis and treatment of Lyme disease as well as co-infections. More than 95% of Lyme disease researchers (n=50) reported that they do not have access to the samples they need for their research, according to a 2016 survey conducted by Lyme Disease Biobank.

Because the bacterial strains which cause many tick-borne infections have been shown to vary from region to region, the Lyme Disease Biobank offers researchers the unique opportunity to explore potential new diagnostics against a range of bacterial strains. Samples from patients and healthy controls are currently available from East Hampton, New York, Martha's Vineyard, Mass., and Marshfield, Wisc., and collections will soon become available from centers in the San Francisco Bay Area, Calif. Each sample undergoes several tests, including Serology (ELISA, Western Immunoblot IgM/IgG; C6 Peptide) and qPCR, in order to confirm the diagnosis of Lyme disease and any co-infections (or for the controls, to rule out a diagnosis). Currently there are samples available from more than 250 individual participants.

Each application for samples from researchers undergoes a peer-review process by three members of the Lyme Disease Biobank reviewer pool, which consists of 39 scientists and clinicians each with specific expertise related to tick-borne illness. The Lyme Disease Biobank Board will use the recommendations of these experts and the Principal Investigator to determine allocation of samples. Approvals will be based on technical merit, potential to advance diagnostics, the likelihood of increasing understanding of Lyme disease and other tick-borne infections, and alignment with the Lyme Disease Biobank scientific goals and objectives. Nine investigators have thus far been approved to receive samples.

Lyme Disease Biobank is fully supported by Bay Area Lyme Foundation, which has received several substantial grants that help fund this effort. Bay Area Lyme Foundation's financial commitment has included: investigations and research to develop criteria for collections and distribution of samples; identification of appropriate initial locations and initiation of collections at pilot sites; enrollment of clinical participants at multiple sites; collection and storage of samples; sample testing; maintenance of the proper environment for samples; and appropriate follow-up on research to ensure completion and scientific collaboration as appropriate. Researchers approved to receive samples are required to pay a nominal fee for samples to cover the cost to retrieve and ship the requested samples.
About Lyme Disease Biobank

Launched in 2015, the Lyme Disease Biobank is collecting human biological samples, including blood and urine samples, from people with early suspected Lyme disease or other tick-borne infections, as well as people who have never had Lyme disease as the control group. The Lyme Disease Biobank is a Type I supporting organization of Bay Area Lyme Foundation. Researchers interested in obtaining samples should visit

About Lyme disease

One of the most common infectious diseases in the country, Lyme disease is a potentially debilitating infection caused by bacteria transmitted through the bite of an infected tick to people and pets. If caught early, most cases of Lyme disease can be effectively treated, but it is commonly misdiagnosed due to lack of awareness and unreliable diagnostic tests. There are about 329,000 new cases of Lyme disease each year, according to statistics released in 2015 by the CDC. As a result of the difficulty in diagnosing and treating Lyme disease, as many as one million Americans may be suffering from the impact of its debilitating long-term symptoms and complications, according to Bay Area Lyme Foundation estimates.

About Bay Area Lyme Foundation

Bay Area Lyme Foundation, a national organization committed to making Lyme disease easy to diagnose and simple to cure, is the leading public not-for-profit sponsor of innovative Lyme disease research in the US. A 501c3 non-profit organization based in Silicon Valley, Bay Area Lyme collaborates with world-class scientists and institutions to accelerate medical breakthroughs for Lyme disease. It is also dedicated to providing reliable, fact-based information so that prevention and the importance of early treatment are common knowledge.

A pivotal donation from The Laurel Foundation covers all overhead costs and allows for 100% of all donor contributions to Bay Area Lyme Foundation to go directly to research and prevention programs. For more information about Lyme disease or to get involved, visit or call us at 650-530-2439.

Bay Area Lyme Foundation

Related Lyme Disease Articles:

New test diagnoses Lyme disease within 15 minutes
Current testing for Lyme disease, called the standard 2-tiered approach or the STT, involves running two complex assays (ELISA and western blot) to detect antibodies against the bacterium, and requires experienced personnel in a lab, and a few hours to carry out and interpret.
An innovative new diagnostic for Lyme disease
In new research, Joshua LaBaer, executive director of the Biodesign Institute at Arizona State University and his colleagues describe an early detection method for pinpointing molecular signatures of the disease with high accuracy.
Mouse, not just tick: New genome heralds change in Lyme disease fight
As Lyme disease increases, researchers have taken a significant step toward finding new ways to prevent its transmission.
Breakthrough paves way for new Lyme disease treatment
Virginia Tech biochemist Brandon Jutras has discovered the cellular component that contributes to Lyme arthritis, a debilitating and extremely painful condition that is the most common late stage symptom of Lyme disease.
Lyme disease predicted to rise in United States as climate warms
A new study looked at the relationship between climatic variables and the incidence of Lyme disease in 15 U.S. states.
More Lyme Disease News and Lyme Disease Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Erasing The Stigma
Many of us either cope with mental illness or know someone who does. But we still have a hard time talking about it. This hour, TED speakers explore ways to push past — and even erase — the stigma. Guests include musician and comedian Jordan Raskopoulos, neuroscientist and psychiatrist Thomas Insel, psychiatrist Dixon Chibanda, anxiety and depression researcher Olivia Remes, and entrepreneur Sangu Delle.
Now Playing: Science for the People

#537 Science Journalism, Hold the Hype
Everyone's seen a piece of science getting over-exaggerated in the media. Most people would be quick to blame journalists and big media for getting in wrong. In many cases, you'd be right. But there's other sources of hype in science journalism. and one of them can be found in the humble, and little-known press release. We're talking with Chris Chambers about doing science about science journalism, and where the hype creeps in. Related links: The association between exaggeration in health related science news and academic press releases: retrospective observational study Claims of causality in health news: a randomised trial This...